Medeon Biodesign Cash Flow Quality Index
Medeon Biodesign cash flow quality index. Medeon Biodesign (6499) has a Cash Flow Quality Index of 0.90x as of March 2022. Operating cash flow of NT$60.74 Million is below net income of NT$67.17 Million, suggesting accrual-heavy earnings not yet converted to cash. See 6499 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Medeon Biodesign (2018–2021)
Cash flow quality index of Medeon Biodesign from 2018 to 2021. Historical Cash Flow Quality Index for Medeon Biodesign across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Medeon Biodesign debt service capacity to assess how comfortably operating cash covers total debt obligations.
Medeon Biodesign Cash Flow Quality Index by Year (2018–2021)
Medeon Biodesign cash flow quality index by year from 2018 to 2021. Year-by-year earnings quality comparison for Medeon Biodesign. For the full cash flow conversion analysis, see 6499 operating cash flow.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -0.14x | NT$-293.38 Million | NT$2.08 Billion | ▼ -111.2% |
| 2018 | 1.26x | NT$322.05 Million | NT$256.60 Million | — |